MTR-07 GLIOBLASTOMA ADAPTATION TO SUSTAINED cdk4/6 INHIBITION INVOLVES SUPPRESSION OF Rb EXPRESSION THROUGH HISTONE H3K4 MODIFICATION

相似書籍

• RB1 SUPPRESSION IS RESPONSIBLE FOR ACQUIRED CDK4/6 INHIBITOR RESISTANCE IN GLIOBLASTOMA
  由: James, C. David, et al.
  出版: (2014)
• MTR-02 MGMT-INHIBITOR IN COMBINATION WITH TGF-β KINASE OR CDK 4/6 INHIBITOR INCREASES TEMOZOLOMIDE SENSITIVITY OF TEMOZOLOMIDE RESISTANT GLIOBLASTOMA CELLS
  由: Das, Arabinda, et al.
  出版: (2015)
• Pharmacologic inhibition of cdk4/6 arrests the growth of glioblastoma multiforme intracranial xenografts
  由: Michaud, Karine, et al.
  出版: (2010)
• MTR-18 PREDICTIVE BIOMARKERS OF BEVACIZUMAB RESPONSE IN RECURRENT GLIOBLASTOMA PATIENTS
  由: Urup, Thomas, et al.
  出版: (2015)
• MTR-15 A PRONEURAL SIGNATURE PROFILE PREDICTS RESISTANCE TO BEVACIZUMAB THERAPY IN GLIOBLASTOMA
  由: Saito, Norihiko, et al.
  出版: (2015)